AskRx Review
Best for: People who want a brand-name-only GLP-1 prescriber routing to NovoCare or LillyDirect.
AskRx is a US telehealth platform whose board-certified physicians exclusively prescribe FDA-approved, brand-name GLP-1 medications for weight loss - no compounded drugs. Offerings include the Wegovy pen and pill (semaglutide) and Zepbound (tirzepatide). AskRx does not dispense, compound, or sell medication; prescriptions are routed to manufacturer pharmacies such as NovoCare and LillyDirect at the patient's choice. A physician subscription runs $99-149/mo and medication is billed separately. LegitScript approved, HIPAA compliant, all 50 states. Subscription may be HSA/FSA eligible.
Medium confidence · Last verified 2026-06-04 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
AskRx is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
AskRx prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| 0.25-0.5 mg (new patient) | brand | $199 |
| all doses | brand | $349 |
| 2.5 mg | brand | $299 |
| 7.5 mg+ | brand | $449 |
✓ Pros
- •Prescribes only FDA-approved brand-name GLP-1s, no compounded drugs
- •LegitScript approved and HIPAA compliant
- •Board-certified physicians trained in obesity medicine
- •Transparent dose-based pricing published on site
- •Available in all 50 states
- •Physician subscription may be HSA/FSA eligible
✗ Cons
- •Cash-pay model; medication cost billed separately by the pharmacy
- •Does not dispense medication itself, so fulfillment depends on third-party pharmacies
- •No compounded lower-cost alternative offered
- •Specific list of supported states is not published
Ready to start with AskRx?
Starting at $199/month. See current pricing and start your free consultation.
Sources & methodology
Our AskRx review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to AskRx
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with AskRx?
Starting at $199/month. See current pricing and start your free consultation.